Our work with communities
We work as a partner with under-served communities in the developed and developing world supporting programmes that are innovative, sustainable and bring real benefit to these communities.
Community news
What we do
We provide money, medicines, time and equipment to non-profit organisations to help improve health and education in under-served communities.
Key fact
Since January 1998, we have donated more than 2 billion albendazole tablets to help eliminate lymphatic filariasis.
Sir Andrew Witty visits Africa
- CEO Andrew Witty visited Kenya and Uganda to see the impact of GSK’s community programmes.
GlaxoSmithKline is an active partner in one of the world's boldest health initiatives.
Find out more about GSK’s commitment to eliminate lymphatic filariasis
Community partnerships
In developing countries, disease results in significant stigma, discrimination, disability and suffering, often trapping people in poverty.
Tackling malaria
Malaria is parasitic disease carried by mosquitoes that kills up to 3 million people a year and is the world's leading cause of childhood mortality.
Our African Malaria Partnership has supported education and behaviour change programmes in Africa through partnerships with non-profit organisations.
ViiV Healthcare effect
PHASE: how hand-washing can save lives
PHASE is hand-washing programme that helps children to avoid life-threatening illness.